PolyPid Ltd

PYPD ·Healthcare, Medical Devices, Israel
Financial Statements Income Statement
Annual Quarterly

Income Statement

Line Item Dec 2025 Jun 2025 Dec 2024 Jun 2024 Dec 2023 Jun 2023 Dec 2022 Jun 2022
Revenue
Cost of Revenue
Gross Profit
Gross Margin
Operating Expenses
Research & Development $6.2M $4.8M $4.0M $8.4M
SG&A Expense $2.5M $1.1M $1.5M $2.2M
Operating Income $-9.4M $-6.1M $-5.8M $-11.6M
Operating Margin
Interest Expense
Pretax Income $-9.9M $-6.3M $-5.8M
Income Tax Expense $53.0K $2.0K $10.0K
Net Income $-10.0M $-6.3M $-5.8M $-11.8M
Net Margin
EPS (Basic) $0.78 $1.25 $3.95 $0.61
EPS (Diluted) $0.78 $1.25 $3.95 $0.61
Shares Outstanding (Basic) 18.2M 12.8M 10.2M 5.0M 1.7M 1.5M 669.6K 19.5M
Shares Outstanding (Diluted) 18.2M 12.8M 10.2M 5.0M 1.7M 1.5M 669.6K 19.5M
Dividends Per Share
← Newer Page 1 of 2 Older →